Current Issue

September 12, 2019: 134 (11)
Blood: 134 (11)

First Edition


  • Review Series: Adolescent and Young Adult Malignant Hematology

    Treating hematologic malignancies in adolescent and young adults (AYA) has unique biologic, therapeutic, and social challenges. Introduced with an editorial by Blood Associate Editor Jorge Cortes, this review series focuses on these unique features in discussing the approach to the AYA population in treating leukemias and lymphomas, with a final review focused on the general psychosocial challenges of this population.

  • Review Series: Emerging Immunotherapies for Hematologic Diseases

    Catherine M. Bollard, MBChB, MD, and Leslie S. Kean, MD, PhD, share highlights of this review series that highlights chimeric antigen receptor T cells and their toxicities, vaccine therapies, and cellular therapies for graft-versus-host disease.

  • Review Series: Update on Hodgkin Lymphoma

    Introduced with an editorial by Blood Associate Editor Laurie H. Sehn, the articles in this series of reviews on Hodgkin lymphoma explore advances in biological insights that have led to the identification of novel targets for drug development and enabled more accurate prognostication. They also examine optimization of various therapeutic strategies for early-stage, advanced-stage, and relapsed disease.